Autoreactive T-cell responses to myeloperoxidase in patients with antineutrophil cytoplasmic antibody-associated vasculitis and in healthy individuals

Modern Rheumatology

Volumn 18, Issue 6, 2008, Pages 593-600

  Seta, Noriyuki ^a   Tajima, Michiko ^b   Kobayashi, Shigeto ^b   Kawakami, Yutaka ^a   Hashimoto, Hiroshi ^b   Kuwana, Masataka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ANCA associated vasculitis; MPO reactive T cell; Myeloperoxidase

Indexed keywords

AMINO ACID; CYCLOPHOSPHAMIDE; EPITOPE; HLA DR ANTIGEN; MYELOPEROXIDASE; PREDNISOLONE;

ADULT; AGED; AMINO ACID SEQUENCE; ANCA ASSOCIATED VASCULITIS; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPHOCYTE CULTURE; MALE; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIGENS; AUTOIMMUNITY; FEMALE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PEROXIDASE; T-LYMPHOCYTES; VASCULITIS; YOUNG ADULT;

EID: 57649149377     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-008-0109-1     Document Type: Article

References (31)

1. Csernok E. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev. 2003;2:158-64.
2. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004;117:39-50.
3. Rarok AA, Limburg PC, Kallenberg CG. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol. 2003;74:3-15.
4. Weidner S, Neupert W, Goppelt-Struebe M, Rupprecht HD. Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro. Arthritis Rheum. 2001;44:1698-706.
5. Savage CO, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol. 1992;141:335-42.
6. Brouwer E, Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol. 1991;83:379-86.
7. Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M, et al. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Association of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol. 2003;30:1534-40.
8. Mathieson PW, Cobbold SP, Hale G, Clark MR, Oliveira DB, Lockwood CM, et al. Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med. 1990;323:250-4.
9. Lockwood CM, Thiru S, Isaacs JD, Hale G, Waldmann H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 1993;341:1620-2.
10. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110:955-63.
11. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-92.
12. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med. 1994;87:671-8.
13. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JWC, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies 2003;349:36-44.
14. Inoko H, Ota M. PCR-RFLP. In: Hui KM, Bidwill JL, editors. Handbook of HLA typing techniques. Boca Raton: CRC Press; 1993. p. 9-70.
15. Kuwana M, Medsger TA Jr, Wright TM. Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides. Clin Immunol Immunopathol. 1995;76:266-78.
16. Maina CV, Riggs PD, Grandea AGIII, Slatko BE, Moran LS, Taquliamonte JA, et al. An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein. Gene 1988;74:365-73.
17. Kuwana M, Medsger TA Jr, Wright TM. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest. 1995;96:586-96.
18. Hattori N, Kuwana M, Kaburaki J, Mimori T, Ikeda Y, Kawakami Y. T cells that are autoreactive to β 2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum. 2000;43:65-75.
19. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest. 1998;102:1393-402.
20. Griffith ME, Coulthart A, Pusey CD. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin Exp Immunol. 1996;103:253-8.
21. Yoshida M, Iwahori T, Nakabayashi I, Akashi M, Watanabe T, Yoshikawa N. In vitro production of myeloperoxidase anti-neutrophil cytoplasmic antibody and establishment of Th1-type T cell lines from peripheral blood lymphocytes of patients. Clin Exp Rheumatol. 2005;23:227-30.
22. Pember SO, Shapira R, Kinkada JM Jr. Multiple forms of myeloperoxidase from human neutrophilic granulocytes: Evidence for differences in compartmentalization, enzymatic activity, and subunit structure. Arch Biochem Biophys. 1993;221:391-403.
23. Kuwana M, Ikeda Y. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura. Int J Hematol. 2005;81:106-12.
24. Kuwana M. β 2-glycoprotein I: Antiphospholipid syndrome and T-cell reactivity. Thromb Res. 2004;114:347-55.
25. King WJ, Brooks CJ, Holder R, Hughes P, Adu D, Savage CO. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin Exp Immunol. 1998;112:539-46.
26. Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol. 1994;98:448-53.
27. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med. 1995;181:1945-8.
28. Kuwana M, Kaburaki J, Kitasato H, Kato M, Kawai S, Kawakami Y, et al. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood 2001;98:130-9.
29. Eguchi K. Apoptosis in autoimmune diseases. Intern Med. 2001;40:275-84.
30. Zipp F. Apoptosis in multiple sclerosis. Cell Tissue Res. 2000;301:163-71.
31. Ito Y, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S, et al. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol. 1993;151:5770-6.